NEW YORK (GenomeWeb News) – Nanosphere today reported that its second-quarter revenues fell 62 percent and its loss grew by 17 percent. 
 
For the quarter ended June 30, 2008, Nanogen’s total revenue fell to $195,000 from $510,000 in the second quarter of 2007.
 
Revenue from grants and contracts fell to zero for the quarter, compared to $503,245 in the prior-year quarter, while product sales grew to $194,715 from $7,025 in the second quarter of 2007.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.